Premium
Symptom burden and information needs in prostate cancer survivors: a case for tailored long‐term survivorship care
Author(s) -
Bernat Jennifer K.,
Wittman Daniela A.,
Hawley Sarah T.,
Hamstra Daniel A.,
Helfand Alexander M.,
Haggstrom David A.,
DarwishYassine May,
Skolarus Ted A.
Publication year - 2016
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.13329
Subject(s) - survivorship curve , medicine , prostate cancer , cancer , odds ratio , population , information needs , confidence interval , logistic regression , odds , sexual function , quality of life (healthcare) , sexual dysfunction , long term care , vitality , gerontology , demography , environmental health , psychiatry , nursing , sociology , world wide web , computer science , philosophy , theology
Objectives To determine the relationship between long‐term prostate cancer survivors’ symptom burden and information needs. Patients and Methods We used population‐based data from the Michigan Prostate Cancer Survivor Study (2499 men). We examined unadjusted differences in long‐term information needs according to symptom burden and performed multivariable logistic regression to examine symptom burden and information needs adjusting for patient characteristics. Results High symptom burden was reported across all domains (sexual 44.4%, urinary 14.4%, vitality 12.7%, bowel 8.4%, emotional 7.6%) with over half of respondents (56%) reporting they needed more information. Top information needs involved recurrence, relationships, and long‐term effects. Prostate cancer survivors with high symptom burden more often searched for information regardless of domain ( P < 0.05). High sexual burden was associated with greater need for information about relationships [odds ratio ( OR ) 2.05, 95% confidence interval ( CI ) 1.54–2.72] and long‐term effects ( OR 1.60, 95% CI 1.23–2.07). High bowel burden was associated with greater information need for long‐term effects ( OR 2.28, 95% CI 1.43–3.63). Conclusions Long‐term prostate cancer survivors with high symptom burden need more supportive information. Tailoring information to these needs may be an efficient approach to support the growing population of long‐term prostate cancer survivors.